Short interest in Range Cancer Therapeutics ETF (NASDAQ:CNCR) decreased during the last reporting period, falling from 6.72K to 6.43K. This put -% of the company's publicly available shares short.

Short interest for Range Cancer Therapeutics ETF gives investors a sense of the degree to which investors are betting on the decline of Range Cancer Therapeutics ETF's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 2.73K shares traded per day, it would take 2.36 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.